Objective
To estimate whether ultrasound measurement of the fetal adrenal gland remote from delivery in asymptomatic women can accurately predict spontaneous preterm birth.
Methods
We conducted a prospective multicenter observational nested cohort study of asymptomatic nulliparous women with a singleton pregnancy to study adverse pregnancy outcomes. Between 22 0/7 and 30 6/7 weeks of gestation, credentialed ultrasonographers measured the width (w), length (l), and when able, depth (d) of the “fetal zone” of the fetal adrenal gland as well as the width (W), length (L) and depth (D) of the total gland. We used the ratios of each measurement (w/W, l/L and d/D) to control for variation in adrenal size by gestational age. The accuracy of each ratio measurement in predicting spontaneous preterm birth <37 0/7 weeks (“SPTB37”) and spontaneous preterm birth <34 0/7 weeks (“SPTB34”) was assessed by receiver operating characteristic (ROC) curves, using area under the curve (AUC).
Results
Pregnancy outcomes were available for 1,697 women with one or more fetal adrenal gland measurements. SPTB37 and SPTB34 occurred in 82 (4.8%) and 6 women (0.4%), respectively. None of the fetal adrenal gland measurements distinguished spontaneous preterm birth from term birth. The AUCs (95% CIs) for SPTB37 were 0.51 (0.45, 0.58), 0.50 (0.44, 0.56), and 0.52 (0.41, 0.63) for w/W, l/L and d/D ratios, respectively. The AUCs for SPTB34 were 0.52 (0.25, 0.79) and 0.55 (0.31, 0.79) for w/W and l/L ratios. Additionally, none of the means of the gland measurements were statistically different between those delivering at term and spontaneous at preterm (p>0.05).
Conclusion
Fetal adrenal size, as measured by ultrasound between 22 0/7 and 30 6/7 weeks, is not predictive of spontaneous preterm birth in asymptomatic nulliparous women.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.